Product ID:PIPE & TANK INSULATION
MSDS Date:12/16/1997
FSC:NIIN:Submitter:N EN
Status Code:A
MSDS Number: CKJZY

OWENS-CORNING, WORLD HEADQUARTERS

ONE OWENS CORNING PARKWAY
TOLEDO, OH 43659
US

Emergency Phone: 419-248-5330

Info Phone: 419-248-8234

Cage: 45255

OWENS-CORNING, WORLD HEADQUARTERS

TOLEDO, OH 43659 US

Telephone: 419-248-8234

Cage: 45255

FIBROUS GLASS

CAS: 65997-17-3

RTECS: LK3651000

OSHA PEL 5 MG/M3

ACGIH TLV: 10 MG/M3

PHENOL, POLYMER WITH FORMALDEHYDE AND UREA

CAS: 25104-55-6

RTECS: SL4600000

OSHA PEL N/K

ACGIH TLV: N/K

FORMALDEHYDE

CAS: 50-00-0

RTECS: LP8925000

OSHA PEL see 1910.1048

ACGIH TLV: N/K

EPA Report Quantity: 100 LBS

DOT Report Quantity: 100 LBS

LD50 LC50 Mixture:SEE TOXICOLOGICAL INFORMATION.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:YES
Health Hazards Acute and Chronic:ACUTE (SHORT TERM): FIBER GLASS WOOL
IS A MECHANICAL IRRITANT AND MAY CAUSE TEMPORARY IRRITATION OF THE
RESPIRATORY TRACT, SKIN AND EYES. CHRONIC (LONG TERM): FIBER GLASS
WOOL IS A POSSIBLE CANCER HAZ ARD. USE OF THESE PRODUCTS HAS NOT
BEEN SHOWN TO CAUSE CANCER IN HUMANS. FIBER GLASS WOOL CAUSED
CANCER IN ANIMALS THROUGH UNNATURAL ROUTES OF EXPOSURE (SURGICAL
IMPLANTATION), BUT HAS NOT PRODUCED C ANCER BY INHALATION. SEE
TOXICOLOGICAL INFORMATION FOR EXPLANATION OF THESE DATA.
Explanation of Carcinogenicity:FORMALDEHYDE: ACGIH A2: SUSPECTED HUMAN
CARCINOGEN. FIBER GLASS WOOL: ACGIH A3: ANIMAL CARCINOGEN. SEE
TOXICOLOGICAL INFORMATION FOR COMPLETE INFORMATION.
Effects of Overexposure:SEE HLTH HAZS. STATE REG INFO: THAT GLASS WOOL
IS NOT LIKELY TO CAUSE CANCER IN HUMANS EXCEPT UNDER
UNCOMMON/UNLIKELY RTES/LEVELS OF EXPOS. TLV-TWA OF 1 RESP FIBER/CC
WAS ADOPTED TO PVNT IRRIT OF RESP TRACT/ANY POSS LONG-TERM RESP
HLTH EFTS IN WORKERS. ANIMAL STUDIES: OVER LAST 50+ YRS THERE HAVE
BEEN NUMEROUS STUDIES ON POTENTIAL HLTH EFTS TO GLASS FIBERS IN
ANIMALS. THERE ARE 2 MAJOR TYPES OF AN IMAL STUDIES: 1) INHAL WHERE
ANIMALS BREATH GLASS WOOL FIBERS, & 2) INSTILLATION STUDIES WHERE
FIBERS ARE INJECTED/SURGICALLY IMPLANTED DIRECTLY INTO ANIMAL.
PLEASE CONT NEHC FOR MORE COMPLETE INFO ON TOXICITY.
Medical Cond Aggravated by Exposure:CHRONIC RESPIRATORY OR SKIN
CONDITIONS MAY TEMPORARILY WORSEN FROM EXPOSURE TO THESE PRODUCTS.

First Aid:INHAL: MOVE TO FRESH AIR. ADMINISTER CARDIAC/PULMONARY
RESUSCITATION (CPR) IF PULSE IS NOT DETECTABLE/IF UNABLE TO
BREATHE. PROVIDE OXYGEN IF BREATHING IS DIFFICULT. OBTAIN MED
ASSIST IF IRRIT PERSIST S. EYES: FLUSH W/RUNNING WATER FOR AT LEAST
15 MINUTES. SEEK MED ATTN IF IRRIT PERSISTS. SKIN: WASH W/MILD SOAP
& RUNNING WATER. USE WASH CLOTH TO HELP REMOVE FIBERS. TO AVOID
FURTHER IRRIT, DO NOT RU B/SCRATCH IRRITATED AREAS.
RUBBING/SCRATCHING MAY FORCE FIBERS INTO SKIN. SEEK MED ATTN IF
IRRIT PERSISTS. INGEST: INGEST IS UNLIKELY. IF IT DOES OCCUR,
OBSERVE INDIVIDUAL FOR SEVERAL DAYS TO INSURE T HAT INTESTINAL
BLOCKAGE DOES NOT OCCUR.

Flash Point:NONE
Lower Limits:NONE
Upper Limits:NONE
Extinguishing Media:WATER, FOAM, CARBON DIOXIDE OR DRY CHEMICAL.
Fire Fighting Procedures:WEAR NIOSH APPROVED SCBA AND FULL PROTECTIVE
EQUIPMENT .
Unusual Fire/Explosion Hazard:THESE PRODUCTS MAY RELEASE ACRID SMOKE IN
A SUSTAINED FIRE. HAZARDOUS COMBUSTION PRODUCTS: PRIMARY COMBUSTION
PRODUCTS ARE CARBON MONOXIDE, CARBON DIOXIDE, AMMONIA AND WATER.
OTHER UNDETERMINED COMPOU NDS COULD BE RELEASED IN SMALL
QUANTITIES.

Spill Release Procedures:LAND SPILL: SCOOP UP/VACUUM MATERIAL & PUT
INTO SUITABLE CONTAINER FOR DISPOSAL AS NON-HAZARDOUS WASTE. WATER
SPILL: MATERIAL WILL SINK & DISPERSE ALONG BOTTOM OF WATERWAYS &
PONDS. IT CAN NOT EASILY BE REMOVED AFTER IT IS WATERBORNE,
HOWEVER, MATERIAL IS NON-HAZARDOUS IN WATER. AIR RELEASE: MATERIAL
WILL SETTLE OUT OF AIR. IT CAN THEN BE SCOOPED UP/VACUUMED FOR
DISPOSAL AS NON-HAZARDOUS WASTE.

Handling and Storage Precautions:NOT APPLICABLE. NO SPECIAL STORAGE OR
HANDLING PROCEDURES ARE REQUIRED FOR THIS MATERIAL.

Respiratory Protection:WHEN TEMP OF SURF BEING INSULATED EXCEEDS
260F(121C)/DURING INITIAL SYS STARTUP, BINDER IN THESE PRODS MAY
UNDERGO VARIOUS DEGREES OF DECOMP DEPENDING ON TEM OF APPLICATION.
NEED FOR RESP PROT WILL VA RY ACCORDING TO AIRBORNE CONC OF FINE
DECOMP PRODS RELEASED & ACCUM IN AREA. IF INSULATION MUST BE
INSTALLED ON HOT SURFS >260F (121C), NIOSH APPRVD (SUP DAT)
Ventilation:GEN DILUTION VENT &/OR LOC EXHST VENT SHOULD BE PROVIDED AS
NEC TO MAINTAIN EXPOS BELOW REG LIMS. DUST COLLECTION SYS SHOULD BE
USED IN OPERATIONS (SUP DAT)
Protective Gloves:IMPERVIOUS GLOVES .
Eye Protection:ANSI APPROVED CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:ANSI APPROVED EMERGENCY EYEWASH AND DELUGE
SHOWER . LOOSE FITTING LONG SLEEVED SHIRT, LONG PANTS.
Supplemental Safety and Health
VENT: INVOLVING CUTTING/MACHINING & MAY BE REQUIRED IN OPERATIONS USING
POWER TOOLS. RESP PROT: FULL FACE RESP APPRVD FOR PROT AGAINST ORG
VAPS SHOULD BE USED. IN AREAS W/GOOD GEN &/OR LOC EXHST VENT,
WHERE EXPOS ARE CONTROLLED BELOW REC PEL/STEL, RESP PROT IS
NORMALLY NOT NEEDED. (OTHER INFO)

Solubility in Water:INSOLUBLE
Appearance and Odor:FIBROUS SOLID WITH ORGANIC ODOR.

Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:NONE, EXCEPT IN FIRE. SEE FIRE
SECTION OF MSDS FOR COMBUSTION PRODUCTS STATEMENT.

Waste Disposal Methods:RCRA HAZARD CLASS: NON-HAZARDOUS. DISPOSE OF IN
ACCORDANCE WITH LOCAL, STATE, AND FEDERAL REGULATIONS .

Toxicological Information:FORMALDEHYDE: LD50 (ORAL RAT): 500-800 MG/KG;
LD50 (DERMAL RABBIT): 270 MG/KG; LC50 (INHAL RAT) (4 HRS): 250-478
PPM. FORMALDEHYDE: IN MARCH 1987 IARC UPGRADED THEIR OVERALL
EVALUATION OF FORMALDEHYDE GAS, BASED ON EVIDENCE OF CARCIN IN
HUMANS, FROM POSS HUMAN CARCIN (GROUP 2B BASED ON INADEQ EVIDENCE
IN HUMANS). A NUMBER OF NEW EPIDEMIOLOGICAL STUDIES ON PERS IN
VARIETY OF OCCUPATIONS W/POTENTIAL EXPOS TO FORMALDEHYDE WERE USED
IN EVALUATION. CANCERS THAT OCCURRED IN EXCESS IN MORE THAN ONE
STUDY ARE: HODGKIN'S DISEASE, LEUKEMIA, & CANCERS OF BUCCAL CAVITY
& PHARYNX (PARTICULARLY NASOPHARYNX) , LUNG, NOSE, (ECOLOGICAL
INFO)

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:NOT TOX TO ANIMALS, PLANTS/FISH. TOX INFO: PROSTATE,
BLADDER, BRAIN, COLON, SKIN & KIDNEY. EXPOS TO FORMALDEHYDE AT
CONCS IN EXCESS OF 1 PPM MAY CAUSE SIGNIFICANT IRRIT OF EYES &
UPPER RESP TRACT. IRR IT THRESHOLD APPEARS TO BE ABOUT 0.3 PPM.
PULM SENSIT, ALTHOUGH RARE, DOES OCCUR IN HUMANS. FORMALDEHYDE
SOLNS CAN CAUSE SEV EYE & MOD SKIN IRRIT. RPTD SKIN EXPOS TO SOLNS
OF 2% OR MORE FORMALDEHYDE H AS CAUSED ALLERGIC SKIN RXNS.
FORMALDEHYDE WASH FOUND TO BE WEAKLY ACTIVE IN A NUMBER OF IN VITRO
GENOTOX TESTS, BUT INACTIVE IN VIVO. FORMALDEHYDE DOES NOT CAUSE
BIRTH DEFECTS IN OFFSPRING OF FEMALE MICE EXPOSED TO CONCS UP
(SARA REG INFO)

Transport Information:DOT SHIPPING NAME: NOT REGULATED. HAZ
CLASS/DIVISION/SECONDARY/IDENTIFICATION #/PACKING GROUP/LABEL(S)
REQUIRED (IF NOT EXCEPTED)/SPECIAL PROVISIONS/PACKAGING
EXCEPTIONS/NON-BULK PACKAGING/BULK PACKAG ING: NONE. EPA HAZ
SUBSTANCES: FORMALDEHYDE. RQ: 100 LBS. QTY LIMITATIONS: PASSENGER
AIRCRAFT/CARGO AIRCRAFT: NONE. MARINE POLLUTANTS: NONE. FREIGHT
DESCRIPTION: (NMFC). HAZ MATL SHIPPING DESCRIPTION: NONE.

SARA Title III Information:ECOLOGICAL INFO: TO 10 PPM. LIFETIME INHAL
OF FORMALDEHYDE AT CONCS >5 PPM FOR 6 HRS/DAY, CAUSED NASAL TUMORS
IN LAB ANIMALS. MANY EPIDEMIOLOGICAL STUDIES HAVE FAILED TO LINK
CANCER IN HUMANS W/OCCUP EXPOS TO FORMALDEHYDE. ACGIH A2
DESIGNATION, SUSPECTED HUMAN CARCIN, IS BASED ON CANCER IN EXPT
ANIMALS & CONFLICTING/INSUFFICIENT EPIDEMIOLOGIC STUDIES OF
WORKERS. REC CEILING TLV OF 0.3 PPM FOR WORK PLACE AIR FORMALDEHYDE
IS BASED ON EVIDENCE OF IRRIT OF OCCUP EXPOS TO FORMALDEHYDE AS
WELL AS HUMAN FORMALDEHYDE EXPOS IN OTHER SETTINGS. FIBER GLASS
WOOL: IARC, IN JUNE 1987, CLASSIFIED FIBER GLASS WOOL AS POSS
CANCER (FED REG INFO)
Federal Regulatory Information:SARA REG INFO: CAUSING AGENT TO HUMANS
(GROUP 2B). THIS CLASSIFICATION WAS BASED ON COMBINED EVALUATION OF
PUBLISHED HUMAN & ANIMAL STUDIES. HUMAN DATA INCLUDED LGE SCALE
MORTALITY STUDIES OF U.S. & E UROPEAN FIBER GLASS WOOL FACTORY
WORKERS. IARC CONCLUDED THAT HUMAN STUDIES DOES NOT PROVIDE
SUFFICIENT EVIDENCE THAT FIBER GLASS WOOL CAUSED CANCER IN HUMANS.
CLASSIFICATION OF FIBER GLASS WOOL AS PO SS CARCIN TO HUMANS WAS
SUBSTANTIALLY BASED ON EXPT ANIMAL STUDIES IN WHICH THEY WERE
EXPOSED TO WOO L GLASS FIBERS THRU NON-NATRL RTES, SUCH AS
INJECTION/IMPLANTATION. IARC REGARDS IT PRUDENT TO TREAT MATL
W/SUFFICIENT (STATE REG INFO)
State Regulatory Information:FED REG INFO: EVIDENCE OF CARCIN IN
ANIMALS AS IF IT IS POSS CARCIN IN HUMANS. IN MAY 1997, ACGIH
ADOPTED AN A3 CARCIN CLASSIFICATION OF SYNTHETIC VITREOUS
FIBERS-GLASS WOOL INSULATION. CLASSIFICATION IS RSLT OF A LENGTHY
REVIEW PROCESS. ACGIH A3 CLASSIFICATION CONSIDERS GLASS WOOL TO BE
CARCIN IN EXPT ANIMALS AT RELATIVELY HIGH DOSES, BY RTES OF ADMIN,
AT SITES/BY MECHANISMS THAT IT DOES NOT CONS IDER RELEVANT TO
WORKER EXPOS. IT ALSO REVIEWED AVAIL EPIDEMIOLOGICAL STUDIES &
CONCLUDED THAT THEY DO NOT CONFIRM INCRD RISK OF CANCER IN EXPOSED
HUMANS. OVERALL ACGIH FOUND THAT AVAIL MED/SCIENTIFIC EVIDENCE
SUGGESTS (EFTS OF OVEREXP)